REDucing Unnecessary Computed Tomography Imaging for MaxillOfacial INjury (REDUCTION)

May 20, 2022 updated by: Romke Rozema, University Medical Center Groningen

A Novel Clinical Decision Aid for the Diagnostic Management of Maxillofacial Trauma: the REDUCTION Trial - REDucing Unnecessary Computed Tomography Imaging for MaxillOfacial INjury

The aim is to prospectively assess the association between clinical parameters and the presence of maxillofacial fractures in trauma patients admitted to the emergency department. Our hypothesis is that a clinical decision aid of critical parameters reduces unnecessary produced CT scans in maxillofacial trauma patients.

Study Overview

Detailed Description

The REDUCTION trial is a prospective multicentre cohort study conducted at the level I emergency departments of the University Medical Center Groningen, Isala hospital (Zwolle, The Netherlands) and the level II trauma center Nij Smellinghe hospital (Drachten, The Netherlands). The increased availability of Computed Tomography (CT) in the emergency department is leading to an overuse for patients with suspected maxillofacial injury. The use of a clinical decision aid could lead to more expedient use of diagnostic imaging within this population of patients. Therefore, all maxillofacial trauma patients admitted to the emergency department are included in this trial if the consultation is within 7 days after trauma. Both maxillofacial trauma patients admitted to CT scan and patients without a radiological confirmed diagnosis are included. The research protocol was approved by the institutional review board of the University Medical Center Groningen (Groningen, The Netherlands). Informed consent was waived as patients are treated according to the standards of care. Upon admission, each patient with maxillofacial injury will be allocated as a midfacial or mandibular trauma. During physical examination, either by the emergency physician or surgical resident, a pre-defined selection of clinical parameters will be assessed focussing on the assessment of potential presence of fractures in the maxillofacial region. The standardization of this examination will be ensured using a pocket map and easy accessible online instructional video's. The clinical parameters, fracture likelihood and physical examination findings will be structurally reported in electronic health record software using a smart tool dedicated for maxillofacial injury. Data regarding patient demographics, mechanism of injury, concomitant injury, diagnostic outcome and radiation dose parameters will be derived from the medical records.

Study Type

Observational

Enrollment (Actual)

1126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Groningen, Netherlands, 9713 GZ
        • University Medical Center Groningen, University of Groningen
    • Friesland
      • Drachten, Friesland, Netherlands, 9202 NN
        • Nij Smellinghe Ziekenhuis
    • Overijssel
      • Meppel, Overijssel, Netherlands, 7943 KA
        • Isala Diaconessenhuis
      • Zwolle, Overijssel, Netherlands, 8000 GK
        • Isala Ziekenhuis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients with a maxillofacial trauma admitted to the emergency department of the cooperating hospitals

Description

Inclusion Criteria:

  • consultation within 7 days of trauma

Exclusion Criteria:

  • history of maxillofacial surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Midfacial fracture suspected patients
Patients who are suspected of maxillofacial fracture
Standarized physical examination dedicated to assess a potential fracture in the maxillofacial or mandibular region.
Mandibular fracture suspected patients
Patients who are suspected of a mandibular fracture
Standarized physical examination dedicated to assess a potential fracture in the maxillofacial or mandibular region.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maxillofacial fracture
Time Frame: Within 1 day, from admission to discharge from the emergency department
The presence of either a maxillofacial or mandibular fracture induced by the trauma and diagnosed using CT or orthopantomography in the emergency department.
Within 1 day, from admission to discharge from the emergency department

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment outcome
Time Frame: Within 2 weeks upon admission to the emegency department

The outcome of the treatment as determined by the Oral and Maxillofacial (OMF) surgeon or emergency physician classified as;

  1. Admission and direct surgical treatment
  2. Admission following elective surgery
  3. Discharge following elective surgery
  4. Discharge, expectative treatment and follow-up after seven days
  5. Discharge, conservative treatment and follow-up after seven days
  6. Discharge, conservative treatment, no follow-up
Within 2 weeks upon admission to the emegency department

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
CT time
Time Frame: Within 2 weeks from admission to the emergency department
Time from admission to CT scanner
Within 2 weeks from admission to the emergency department
Emergency department total time of admission
Time Frame: Within 2 weeks from admission to the emergency department
Total time the patient was of admitted at the emergency department
Within 2 weeks from admission to the emergency department

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fred KL Spijkervet, DMD PhD, University of Groningen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

September 30, 2019

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

October 4, 2017

First Submitted That Met QC Criteria

October 18, 2017

First Posted (Actual)

October 19, 2017

Study Record Updates

Last Update Posted (Actual)

May 23, 2022

Last Update Submitted That Met QC Criteria

May 20, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Craniocerebral Trauma

Clinical Trials on Standardized physical examination

3
Subscribe